呼吸器感染症に対するcefluprenamの臨床的検討

書誌事項

タイトル別名
  • Clinical studies on cefluprenam in respiratory tract infections

この論文をさがす

抄録

Efficacy and safty of cefluprenam (CFLP) were evaluated on 6 cases comprising 1 pneumonia, 1 lung abscess, 2 bronchiectasis with infection, 1 pulmonary fibrosis with infection and 1 pulmonary emphysema with infection.CFLP was administered intravenously at a dosage of lg twice a day in the morning and evening for 7 to 21 days.Clinical responses were excellent or good in 5 cases but poor in 1 case with lung abscess.<BR>The causative organisms comprizing 1 Haemophilus parainfluenzae, 1 Klebsiella pneumoniae, 1 Proteus mirabilis and 2 Pseudomonas aeruginosa were eradicated. No adverse drug reactions and abnormal laboratory changes were observed.

収録刊行物

参考文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ